Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.08
+0.180 (+4.62%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Nov 10, 2022 $20.31 $21.05 $19.17 $20.89 1 740 524
Nov 09, 2022 $19.37 $19.43 $18.54 $18.73 1 006 361
Nov 08, 2022 $20.00 $20.60 $19.31 $19.61 1 835 342
Nov 07, 2022 $19.96 $20.10 $18.96 $19.68 1 381 756
Nov 04, 2022 $20.52 $21.95 $18.71 $19.84 2 298 752
Nov 03, 2022 $19.71 $20.34 $19.00 $19.45 1 624 651
Nov 02, 2022 $20.76 $21.49 $19.82 $20.04 1 766 954
Nov 01, 2022 $21.64 $21.74 $20.82 $20.99 883 352
Oct 31, 2022 $21.51 $21.80 $20.81 $20.92 975 138
Oct 28, 2022 $20.65 $21.96 $20.45 $21.80 1 433 118
Oct 27, 2022 $21.20 $21.21 $20.08 $20.65 1 314 218
Oct 26, 2022 $19.51 $22.20 $19.51 $20.85 1 725 656
Oct 25, 2022 $19.08 $19.90 $19.08 $19.66 1 331 318
Oct 24, 2022 $19.47 $19.47 $18.46 $18.91 840 436
Oct 21, 2022 $19.06 $19.49 $18.65 $19.29 1 235 117
Oct 20, 2022 $19.64 $20.04 $18.73 $19.04 1 350 779
Oct 19, 2022 $21.17 $21.30 $19.40 $19.68 1 602 338
Oct 18, 2022 $21.65 $22.40 $20.76 $21.64 1 113 700
Oct 17, 2022 $21.15 $21.43 $20.57 $21.08 1 372 445
Oct 14, 2022 $21.83 $21.93 $20.33 $20.36 746 233
Oct 13, 2022 $20.21 $21.69 $19.98 $21.45 1 067 045
Oct 12, 2022 $21.05 $21.55 $20.55 $21.33 882 772
Oct 11, 2022 $21.40 $21.95 $20.29 $20.93 1 805 969
Oct 10, 2022 $21.92 $22.06 $20.95 $21.32 1 029 933
Oct 07, 2022 $22.56 $22.69 $21.31 $21.47 1 105 814
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT